Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

Not enough completed buys to draw the outcome line yet.

1 of 1
buys higher ~6mo later
+41.5%
median outcome
+2.3%
S&P 500 median, same spans

Disclosed positions

Estimated from their latest filings — positions may have changed since

$112.08M
combined est. value
LBRX
LB PHARMACEUTICALS INC
$112.08M
3,352,804 sh

Activity

Open-market buy & sell volume

BuySell
0$20.0M$40.0M2025 · bought $40.0M · sold $22.4M2025
Total +$40.00M bought · −$22.35M sold
Most bought
LBRX
$40.00M

All filings on record

Every Form 4 transaction we track for this filer

DVAXOther
2026-02-10 · DYNAVAX TECHNOLOGIES CORP
15,726,349
—
LBRXBuy
2025-09-12 · LB PHARMACEUTICALS INC
$10.00M
+41.5%
LBRXBuy
2025-09-12 · LB PHARMACEUTICALS INC
$30.00M
+41.5%
LBRXConvert
2025-09-12 · LB PHARMACEUTICALS INC
686,138
—
DVAXSell
2025-08-22 · DYNAVAX TECHNOLOGIES CORP
$10.27M
—
DVAXSell
2025-08-21 · DYNAVAX TECHNOLOGIES CORP
$12.08M
—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.